{"id":58096,"date":"2021-11-11T13:00:45","date_gmt":"2021-11-11T13:00:45","guid":{"rendered":"https:\/\/www.atlasrleye.com\/exudative-armd\/"},"modified":"2025-07-15T22:06:25","modified_gmt":"2025-07-15T22:06:25","slug":"exudative-armd","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/age-related-macular-degeneration\/exudative-armd\/","title":{"rendered":"Exudative ARMD"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”AGE-RELATED MACULAR DEGENERATION” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231635506431773-0d8d0743-1f0b|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” add_icon=”true” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading source=”post_title” font_container=”tag:h1|font_size:44px|text_align:center|color:%235f1b52″ use_theme_fonts=”yes”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″][vc_column_text]<\/p>\n
\n

Wet AMD is characterized by the presence of choroidal neovascularization (CNV). CNV develops when a bud of neovascular tissue, arising from the choriocapillaris, grows through a break in Bruch\u2019s membrane and reaches the sub-RPE space. Usually the new vessels are accompanied by fibroblasts and collagen deposits. The end result is the formation of a fibrovascular complex.<\/p>\n

Patients may complain of sudden loss of vision, methamorphopsias and a paracentral scotoma.<\/p>\n

Fundoscopy may reveal subretinal or intra-retinal lipids, fluid or blood. RPE detachment and tears may also occur. Fluorescein angiography is an essential examination for the diagnosis of CNV. Two basic angiographic have been described: the classic and the occult CNV. Indocyanine green angiography (ICG) can offer additional information in cases of occult CNV.<\/p>\n

Optical coherence tomography (OCT) is the examination of choice for the follow-up of this group of patients.<\/p>\n

Today, the therapy of choice today is intravitreal injection of anti-VEGF agents.<\/p>\n

Differential Diagnosis:<\/p>\n